Last Price
0.468
Today's Change
+0.002 (0.42%)
Day's Change
0.444 - 0.477
Trading Volume
186,880
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Meeshanthini V. Dogan Ph.D. Dr. Meeshanthini V. Dogan Ph.D.
Full Time Employees: 7 7
IPO Date: 2022-01-14 2022-01-14
CIK: 0001870144 0001870144
ISIN: US14159C1036 US14159C1036
CUSIP: 14159C103 14159C103
Beta: 4.89 4.89
Last Dividend: 0.00 0.00
Dcf Diff: 0.47 0.47
Dcf: -0.00 -0.00
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.